These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial. Schellenberg D; Gabos Z; Duimering A; Debenham B; Fairchild A; Huang F; Rowe LS; Severin D; Giuliani ME; Bezjak A; Lok BH; Raman S; Chung P; Zhao Y; Ho CK; Lock M; Louie AV; Lefresne S; Carolan H; Liu M; Yau V; Ye A; Olson RA; Mou B; Mohamed IG; Petrik DW; Dosani M; Pai H; Valev B; Gaede S; Warner A; Palma DA Int J Radiat Oncol Biol Phys; 2025 Jan; 121(1):28-38. PubMed ID: 39168356 [TBL] [Abstract][Full Text] [Related]
31. Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach. Comito T; Cozzi L; Clerici E; Campisi MC; Liardo RL; Navarria P; Ascolese A; Tozzi A; Iftode C; De Rose F; Villa E; Personeni N; Rimassa L; Santoro A; Fogliata A; Mancosu P; Tomatis S; Scorsetti M BMC Cancer; 2014 Aug; 14():619. PubMed ID: 25163798 [TBL] [Abstract][Full Text] [Related]
32. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Ball D; Mai GT; Vinod S; Babington S; Ruben J; Kron T; Chesson B; Herschtal A; Vanevski M; Rezo A; Elder C; Skala M; Wirth A; Wheeler G; Lim A; Shaw M; Schofield P; Irving L; Solomon B; Lancet Oncol; 2019 Apr; 20(4):494-503. PubMed ID: 30770291 [TBL] [Abstract][Full Text] [Related]
33. A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II). Siva S; Kron T; Bressel M; Haas M; Mai T; Vinod S; Sasso G; Wong W; Le H; Eade T; Hardcastle N; Chesson B; Pham D; Høyer M; Montgomery R; Ball D BMC Cancer; 2016 Mar; 16():183. PubMed ID: 26944262 [TBL] [Abstract][Full Text] [Related]
34. Safety and Survival Rates Associated With Ablative Stereotactic Radiotherapy for Patients With Oligometastatic Cancer: A Systematic Review and Meta-analysis. Lehrer EJ; Singh R; Wang M; Chinchilli VM; Trifiletti DM; Ost P; Siva S; Meng MB; Tchelebi L; Zaorsky NG JAMA Oncol; 2021 Jan; 7(1):92-106. PubMed ID: 33237270 [TBL] [Abstract][Full Text] [Related]
35. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy. Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637 [TBL] [Abstract][Full Text] [Related]
36. Systematic review of the efficacy of stereotactic ablative radiotherapy for oligoprogressive disease in metastatic cancer. Doyle E; Killean AJ; Harrow S; Phillips ID Radiother Oncol; 2024 Jul; 196():110288. PubMed ID: 38648995 [TBL] [Abstract][Full Text] [Related]
37. Long-term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer. Wijetunga NA; Dos Anjos CH; Zhi WI; Robson M; Tsai CJ; Yamada Y; Dover L; Gillespie EF; Xu AJ; Yang JT Cancer Med; 2021 Aug; 10(15):5163-5174. PubMed ID: 34159748 [TBL] [Abstract][Full Text] [Related]
38. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases. Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496 [TBL] [Abstract][Full Text] [Related]
39. Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer. Mercier C; Claessens M; De Troyer B; Debacker T; Fransis K; Vandeursen H; Ost P; Dirix P Front Oncol; 2022; 12():863609. PubMed ID: 35494057 [TBL] [Abstract][Full Text] [Related]
40. Stereotactic Ablative Radiation Therapy for Pulmonary Recurrence-Based Oligometastatic Non-Small Cell Lung Cancer: Survival and Prognostic Value of Regulatory T Cells. Liu C; Sun B; Hu X; Zhang Y; Wang Q; Yue J; Yu J Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1055-1064. PubMed ID: 31437470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]